Sweden: Biotage to acquire outstanding shares of ATDBio

Biotage, the global impact tech company, has agreed to acquire all outstanding shares in ATDBio in the UK, for a total purchase price of approximately £45m (US$62m). The deal is financed through a combination of a Skr190m (US$22m) share issue of new ordinary Biotage shares, around Skr344m cash at hand and a revolving credit facility….

You must be a HMI Subscriber to view this content.

Subscribe Now »